Trial Profile
Observational Study of Glycaemic Control in Type 2 Diabetic Patients Uncontrolled on Oral Antidiabetic Agents and Starting With Once Daily Levemir (Insulin Detemir) - 24 Weeks, Prospective, Multicentre Observational Study in Hungary.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms HA-BOT
- Sponsors Novo Nordisk
- 29 Jun 2012 Actual number of patients changed from 500 to 1032, as reported by ClinicalTrials.gov.
- 19 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 May 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.